Skip to main content
Premium Trial:

Request an Annual Quote

US Genomics Awarded SBIR Grant for Genomic Mapping Technology Development

NEW YORK, Sept. 29 (GenomeWeb News) - US Genomics said today that it has received a $500,000 phase II SBIR grant from the National Science Foundation to support the development of its DNA analysis and genomic mapping technologies.

 

The grant, said the Woburn, Mass.-based company, is a follow on to a phase I SBIR grant that funded the generation of genomic maps based on analyses of individual DNA molecules.

 

US Genomics said that the second grant will support the optimization of the company's nanofluidics, the development of novel fluorescence detection strategies, and the design of simpler and more rapid methods to prepare and isolate samples.

 

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.